Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
Tax withholdingCommon Stock | 9,673 | $115.67 | $1,118,875.91 |
DisclosureSEC source: 0001225208-17-003497 · doc4.xml · nonDerivative · entry 3 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,929.4236 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
GrantCommon Stock | 6,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003497 · doc4.xml · nonDerivative · entry 2 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,602.4236 F2 · shares: Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
Exercise / conversionCommon Stock | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003497 · doc4.xml · nonDerivative · entry 1 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,405.4236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantRetention Restricted Share Units · Derivative | 70,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,733 Underlying: Common Stock · 70,733 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantRestricted Share Units · Derivative | 10,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,374 Underlying: Common Stock · 10,374 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionPerformance Share Units · Derivative | 22,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,298 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 123,291 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,291 Underlying: Common Stock · 123,291 shares Expires 2027-02-13 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Tax withholdingCommon Stock | 16,175 | $115.67 | $1,870,962.25 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,536 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantCommon Stock | 8,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,711 F2 · shares: Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionCommon Stock | 22,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:02 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
GrantRestricted Share Units · Derivative | 7,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003499 · doc4.xml · derivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,106 Underlying: Common Stock · 7,106 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:02 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 84,454 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0001225208-17-003499 · doc4.xml · derivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,454 Underlying: Common Stock · 84,454 shares Expires 2027-02-13 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionRestricted Share Units · Derivative | 10,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003258 · doc4.xml · derivative · entry 5 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Tax withholdingCommon Stock | 3,699 | $115.13 | $425,865.87 |
DisclosureSEC source: 0001225208-17-003258 · doc4.xml · nonDerivative · entry 2 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,753 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionCommon Stock | 10,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003258 · doc4.xml · nonDerivative · entry 1 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionRestricted Share Units · Derivative | 8,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Tax withholdingCommon Stock | 3,363 | $115.13 | $387,182.19 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,516 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionCommon Stock | 8,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 6,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003260 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,239 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,345 | $115.13 | $269,979.85 |
DisclosureSEC source: 0001225208-17-003260 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,301.0055 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 6,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003260 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,646.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Gorsky AlexChairman, CEO
|
Exercise / conversionRestricted Share Units · Derivative | 33,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003261 · doc4.xml · derivative · entry 5 Gorsky Alex · CIK 0001453149 · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Gorsky AlexChairman, CEO
|
Tax withholdingCommon Stock | 14,251 | $115.13 | $1,640,717.63 |
DisclosureSEC source: 0001225208-17-003261 · doc4.xml · nonDerivative · entry 2 Gorsky Alex · CIK 0001453149 · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,318 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Gorsky AlexChairman, CEO
|
Exercise / conversionCommon Stock | 33,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003261 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
PETERSON SANDRA EExec VP, Group WW Chairman
|
Exercise / conversionRestricted Share Units · Derivative | 11,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003262 · doc4.xml · derivative · entry 3 PETERSON SANDRA E · CIK 0001192752 · Exec VP, Group WW Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
PETERSON SANDRA EExec VP, Group WW Chairman
|
Tax withholdingCommon Stock | 4,942 | $115.13 | $568,972.46 |
DisclosureSEC source: 0001225208-17-003262 · doc4.xml · nonDerivative · entry 2 PETERSON SANDRA E · CIK 0001192752 · Exec VP, Group WW Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,769 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
PETERSON SANDRA EExec VP, Group WW Chairman
|
Exercise / conversionCommon Stock | 11,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003262 · doc4.xml · nonDerivative · entry 1 PETERSON SANDRA E · CIK 0001192752 · Exec VP, Group WW Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionRestricted Share Units · Derivative | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Tax withholdingCommon Stock | 3,600 | $115.13 | $414,468.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,678.416 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionCommon Stock | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,278.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
Exercise / conversionRestricted Share Units · Derivative | 6,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003263 · doc4.xml · derivative · entry 4 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
Tax withholdingCommon Stock | 1,970 | $115.13 | $226,806.10 |
DisclosureSEC source: 0001225208-17-003263 · doc4.xml · nonDerivative · entry 2 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,873.4236 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
Exercise / conversionCommon Stock | 6,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003263 · doc4.xml · nonDerivative · entry 1 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,843.4236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 5,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003265 · doc4.xml · derivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,840 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 3,029 | $115.13 | $348,728.77 |
DisclosureSEC source: 0001225208-17-003265 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,265.882 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 5,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003265 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,294.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionRestricted Share Units · Derivative | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003266 · doc4.xml · derivative · entry 5 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,221 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Kapusta Ronald AController, CAO
|
Tax withholdingCommon Stock | 1,042 | $115.13 | $119,965.46 |
DisclosureSEC source: 0001225208-17-003266 · doc4.xml · nonDerivative · entry 2 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,904 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionCommon Stock | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003266 · doc4.xml · nonDerivative · entry 1 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:05 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 27,735 | $0.00 Strike: $65.62 | $0.00 |
DisclosureSEC source: 0001225208-17-002311 · doc4.xml · derivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,735 shares Expires 2017-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:05 UTC |
Ullmann Michael HExec VP, General Counsel
|
SaleCommon Stock | 21,735 | $112.88 | $2,453,442.45 |
DisclosureSEC source: 0001225208-17-002311 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,454.882 F1 · price: This transaction was executed in multiple trades at prices ranging from $112.790 to $112.970. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:05 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 27,735 | $65.62 | $1,819,970.70 |
DisclosureSEC source: 0001225208-17-002311 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,189.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2016 Filed Dec 9, 2016 00:19 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 414.384 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-042924 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,839.608 Underlying: Common Stock · 414.384 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 06, 2016 Filed Dec 9, 2016 00:19 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 381.325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-042925 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,175.225 Underlying: Common Stock · 381.325 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 06, 2016 Filed Dec 9, 2016 00:19 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 329.951 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-042926 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,176.9653 Underlying: Common Stock · 329.951 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 17:52 UTC |
PRINCE CHARLESDirector
|
PurchaseCommon Stock | 875 | $114.11 | $99,846.25 |
DisclosureSEC source: 0001225208-16-040730 · doc4.xml · nonDerivative · entry 1 PRINCE CHARLES · CIK 0001225179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,520 Read SEC document |
| September 06, 2016 Filed Sep 9, 2016 20:09 UTC |
LINDQUIST SUSAN LDirector
|
GrantDeferred Share Units · Derivative | 475.059 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039186 · doc4.xml · derivative · entry 1 LINDQUIST SUSAN L · CIK 0001276829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,728.755 Underlying: Common Stock · 475.059 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 06, 2016 Filed Sep 9, 2016 20:09 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 386.487 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039187 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425.224 Underlying: Common Stock · 386.487 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 06, 2016 Filed Sep 9, 2016 20:09 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 307.736 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039188 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,847.0143 Underlying: Common Stock · 307.736 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 06, 2016 Filed Sep 9, 2016 20:09 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 355.652 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039189 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,793.9 Underlying: Common Stock · 355.652 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.